Post-earnings recap
Reported
Fri, Feb 21, 2025
EPS actual
$1.98
EPS est.
$0.06
EPS surprise
+3042.86%
1-day move
+0.68%
Protagonist Therapeutics reported a significant earnings surprise with an EPS of $1.98, which boosted investor confidence, reflected in the 0.68% rise in stock price. However, the absence of revenue figures and guidance leaves some uncertainty about future performance. Investors may be encouraged by the strong EPS but will be looking for more clarity in upcoming reports.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.98 | N/A | +3042.86% |
| Revenue | N/A | N/A | N/A |
Management remains cautiously optimistic about the company's direction following the strong EPS results. They emphasized their commitment to advancing their pipeline.
Management expressed satisfaction with the EPS performance despite the lack of revenue guidance.
They highlighted ongoing efforts in research and development as key to future growth.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—